Initial results of the oesophageal and gastric cancer registry from the Comunidad Valenciana

• Published in: Cirugia Española Vol. 95; no. 8; p. 428
• Main Authors: Escrig, Javier, Mingol, Fernando, Martí, Roberto, Puche, José, Trullenque, Ramón, Barreras, José Antonio, Asencio, Francisco, Aguiló, Javier, Navarro, José Manuel, Alberich, Carmen, Salas, Dolores, Lacueva, Francisco Javier
• Format: Journal Article
• Language: English; Spanish
• Published: Spain 01-10-2017
• Subjects: Aged; Aged, 80 and over; Carcinoma - surgery; Esophageal Neoplasms - surgery; Female; Humans; Male; Middle Aged; Registries; Spain; Stomach Neoplasms - surgery; Postoperative mortality; Oesophageal cancer; Mortalidad postoperatoria; Registro; Cáncer de esófago; Registry; Gastric cancer; Indicadores; Cáncer gástrico; Outcomes
• ISSN: 1578-147X
• DOI: 10.1016/j.ciresp.2017.07.004

To evaluate the initial results of the oesophagogastric cancer registry developed for the Sociedad Valenciana de Cirugía and the Health Department of the Comunidad Valenciana (Spain).
Fourteen of the 24 public hospitals belonging to the Comunidad Valenciana participated. All patients with diagnosis of oesophageal or gastric carcinomas operated from January 2013 to December 2014 were evaluated. Demographic, clinical and pathological data were analysed.
Four hundred and thirty-four patients (120 oesophageal carcinomas and 314 gastric carcinomas) were included. Only two hospitals operated more than 10 patients with oesophageal cancer per year. Transthoracic oesophaguectomy was the most frequent approach (84.2%) in tumours localized within the oesophagus. A total gastrectomy was performed in 50.9% patients with gastroesophageal junction (GOJ) carcinomas. Postoperative 30-day and 90-day mortality were 8% and 11.6% in oesophageal carcinoma and 5.9 and 8.6% in gastric carcinoma. Before surgery, middle oesophagus carcinomas were treated mostly (76,5%) with chemoradiotherapy. On the contrary, lower oesophagus and GOJ carcinomas were treated preferably with chemotherapy alone (45.5 and 53.4%). Any neoadjuvant treatment was administered to 73.6% of gastric cancer patients. Half patients with oesophageal carcinoma or gastric carcinoma received no adjuvant treatment.
This registry revealed that half patients with oesophageal cancer were operated in hospitals with less than 10 cases per year at the Comunidad Valenciana. Also, it detected capacity improvement for some clinical outcomes of oesophageal and gastric carcinomas.